Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We show that high doses of salicylates reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling. Activation or overexpression of the IκB kinase β (IKKβ) attenuated insulin signaling in cultured cells, whereas IKKβ inhibition reversed insulin resistance. Thus, IKKβ, rather than the cyclooxygenases, appears to be the relevant molecular target. Heterozygous deletion ( Ikkβ +/− ) protected against the development of insulin resistance during high-fat feeding and in obese Lep ob/ob mice. These findings implicate an inflammatory process in the pathogenesis of insulin resistance in obesity and type 2 diabetes mellitus and identify the IKKβ pathway as a target for insulin sensitization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“Along these lines, numerous insulin-resistant states (e.g., obesity, type 2 diabetes, and lipid/heparin infusion) are associated with increased activation of JNK (18,21) and/or IKK (21)(22)(23)(24)(25) in parallel with inhibitory serine phosphorylation of IRS-1 (18,21).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“JNK (18,21) and IKK (22,25) signaling are upregulated and activated in insulin-resistant human and rodent skeletal muscle.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
Self-citationZandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., & Karin, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80406-7 · Cited by 1,812
Self-citationInhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene
Li, Q., Antwerp, D. V., Mercurio, F., Lee, K.-F., & Verma, I. M. (1999) · Science · doi:10.1126/science.284.5412.321 · Cited by 963
The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling
Karin, M., & Delhase, M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0210 · Cited by 955
Self-citation
Research works printed but not linked: 2
- Ebstein W., Berl. Klin. Wochnschr. 13, 337 (1876).
- Supplementary Web material is available on Science Online at www.sciencemag.org/cgi/content/full/293/5535/1673/DC1.
Cited by
Items 901–999 of 999
Effects of Vaspin on Insulin Resistance in Rats and Underlying Mechanisms
Liu, S., Duan, R., Wu, Y., Du, F., Zhang, J., Li, X., Guo, S., Wang, M., Zhang, Q., Li, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31923-3 · Cited by 48
Baek, Y., Lee, M. N., Wu, D., & Pae, M. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.06.002 · Cited by 47
Shojima, N., Ogihara, T., Inukai, K., Fujishiro, M., Sakoda, H., Kushiyama, A., Katagiri, H., Anai, M., Ono, H., Fukushima, Y., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1735-1 · Cited by 49
Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation
Chakravarthy, M. V., Zhu, Y., Li, Y., Coleman, T., Pappan, K. L., Marshall, C. A., McDaniel, M. L., & Semenkovich, C. F. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800379-jlr200 · Cited by 46
JIANG, G., DALLAS-YANG, Q., BISWAS, S., LI, Z., & ZHANG, B. B. (2004) · Biochemical Journal · doi:10.1042/bj20031207 · Cited by 45
Self-citationWalters, T. S., McIntosh, D., Ingram, S., Tillery, L., Motley, E. D., Arinze, I., & Misra, S. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000351 · Cited by 48
“Some studies have shown that Nrf2 is involved in cross-talk with NF-kB, p53 and AhR [81], which are involved in inflammation, immune response, Alzheimer disease, cancer, diabetes and arthritis [82–86].”
Inhibitor κB kinase is involved in the paracrine crosstalk between human fat and muscle cells
Dietze‐Schroeder, D., Ramrath, S., Ritzeler, O., Tennagels, N., Hauner, H., & Eckel, J. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802701 · Cited by 50
“Interestingly, salicylates are able to decrease the serine and threonine phosphorylation and enhance the tyrosine phosphorylation of IRS-1 in obese Zucker rats”
BackgroundAnderson, C. D., Upadhya, G. A., Conzen, K. D., Jia, J., Brunt, E. M., Tiriveedhi, V., Xie, Y., Ramachandran, S., Mohanakumar, T., Davidson, N. O., et al. (2010) · Liver Transplantation · doi:10.1002/lt.22220 · Cited by 44
“NAFLD is strongly associated with metabolic syndrome, a combination of abnormalities related to insulin resistance and adipose tissue–derived proinflammatory factors that increase the hepatic inflammatory response.(1,13,14)”
BackgroundHypothalamic control of energy and glucose metabolism
Sisley, S. R., & Sandoval, D. A. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9189-x · Cited by 50
“Systemic anti-inflammatory agents, such as salicylate, have proven effective in reversing insulin resistance in T2DM patients [128, 129] via inhibition of the nuclear factor kappa B (NFκB) pathway [130, 131].”
Gao, Z., Yin, J., Zhang, J., He, Q., McGuinness, O. P., & Ye, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007260 · Cited by 47
Meng, R., Zhu, D., Bi, Y., Yang, D., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053557 · Cited by 46
“Given that TNF-a and IL-6 as well as the NF-kB activation are crucial for the development of glucose intolerance and insulin resistance [22,24,38], our data support the notion that inhibition of inflammation-related NF-kB activation may be a promising strategy for the intervention of glucose intolerance.”
BackgroundMolecular mechanisms of inflammation in obesity-linked insulin resistance
Marette, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802500 · Cited by 44
Yamashita, A. S., Lira, F. S., Neto, J. C. R., Paulino, E. C., Brum, P. C., Negrão, C. E., dos Santos, R. V. T., Júnior, M. L. B., do Nascimento, C. O., Oyama, L. M., et al. (2010) · Cytokine · doi:10.1016/j.cyto.2010.07.006 · Cited by 48
Hebi, M., Farid, O., Ajebli, M., & Eddouks, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.111 · Cited by 44
“articulata markedly improved liver cellular population likely by overcoming the diabetic complications as reported by similar study [29].”
ResultParasite excretory‐secretory products and their effects on metabolic syndrome
Crowe, J., Lumb, F. E., Harnett, M. M., & Harnett, W. (2017) · Parasite Immunology · doi:10.1111/pim.12410 · Cited by 45
Du, Q., Zhang, S., Li, A., Mohammad, I. S., Liu, B., & Li, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00015 · Cited by 47
“In obesity, the adipose tissue frequently represents inflammation, endoplasmic reticulum (ER) stress and dysregulation of adipokine expression, which contribute to diabetes and insulin resistance through various mechanisms (Yuan et al., 2001; Greenberg and Obin, 2006; Wang et al., 2016).”
BackgroundOxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases
Scazzocchio, B., Varí, R., D’Archivio, M., Santangelo, C., Filesi, C., Giovannini, C., & Masella, R. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800402-jlr200 · Cited by 231
“As a point of fact, high doses of aspirin or salicylate, which inhibit IKKb activity (88), have been shown to reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing the animals to insulin signaling (89, 90).”
BackgroundProbiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases
Strowski, M. Z., & Wiedenmann, B. (2009) · Gut · doi:10.1136/gut.2009.179325 · Cited by 50
“of aspirin) or experimental deletion of receptors for inflammatory cytokines results in increased insulin sensitivity and improved pancreatic beta-cell function, which is paralleled by a reduction of hyperglycaemia and loss of body weight.(4) 5 Despite numerous studies describing the activation of proinflammatory cyto…”
BackgroundInsulin as an anti-inflammatory and antiatherosclerotic hormone
Dandona, P., Dhindsa, S., Aljada, A., & Garg, R. (2003) · Clinical cornerstone · doi:10.1016/s1098-3597(03)90062-7 · Cited by 47
“Conversely, the administration of the classic anti-inflammatory drug, aspirin, results in the resolution of insulin resistance (68).”
BackgroundEffects of anti-inflammatory therapies on glycemic control in type 2 diabetes mellitus
Li, D., Zhong, J., Zhang, Q., & Zhang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125116 · Cited by 64
“Salsalate, a prodrug form of salicylate, shows anti-inflammatory effects by inhibiting the IKKb/NF-kB and JNK signaling pathways (46, 47).”
BackgroundNIRANJAN, S., Phillips, B. E., & Giannoukakis, N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193373 · Cited by 51
“With the activation of leukocytes inside the liver, such as macrophages, growing intra-hepatic lipid deposition results in immunokine release [reviewed in (79) and (80)] which potentiates adipocyte lipolysis (81) concomitant to inhibition of hepatic insulin signaling (81, 82).”
BackgroundTian, F., Zhang, Y. J., Li, Y., & Xie, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083819 · Cited by 47
The regulation of muscle protein turnover in diabetes
Workeneh, B., & Bajaj, M. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.028 · Cited by 47
Komathi, S., Gopalan, A., Nallal, M., & Lee, K.-P. (2017) · RSC Advances · doi:10.1039/c6ra24760a · Cited by 43
Meta-inflammation and cardiometabolic disease in obesity: Can heat therapy help?
Ely, B. R., Clayton, Z. S., McCurdy, C. E., Pfeiffer, J. D., & Minson, C. T. (2017) · Temperature · doi:10.1080/23328940.2017.1384089 · Cited by 50
“Additionally, anti-inflammatory therapy (salicylates) has been shown to reverse insulin resistance in obese rodents.(13) These findings led to the current theory that inflammation drives obesity-induced insulin resistance.”
BackgroundRole of oxidative stress and inflammation in the origin of Type 2 diabetes – a paradigm shift
Pillarisetti, S., & Saxena, U. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.401 · Cited by 49
“IKKβ Activation of NF-κB Inactivation of IRS-1 Inhibitors [20,22,23]”
BackgroundMethodBeck Jørgensen, S., O’Neill, H. M., Hewitt, K., Kemp, B. E., & Steinberg, G. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1483-8 · Cited by 42
“The combination of inflammation and accumulation of bioactive lipids is hypothesised to antagonise insulin signalling and insulin-stimulated glucose uptake by activating c-jun Nterminal kinase [3], inhibitory kappa beta kinase [4], protein kinase C theta [5] and protein phosphatase 2A [6].”
Flores, M. (2005) · Nutrition Research Reviews · doi:10.1079/nrr2005104 · Cited by 49
“It has been demonstrated experimentally both in animals and human subjects that the administration of IL-6 induces gluconeogenesis, which leads to hyperglycaemia and compensatory hyperinsulinaemia (Stevenson et al. 1999; Yuan et al. 2001).”
The influence of endotoxemia on the molecular mechanisms of insulin resistance.
Moreira, A. P. B., & Alfenas, R. D. C. G. (2012) · PubMed · doi:10.1590/s0212-16112012000200007 · Cited by 42
Wang, N., Tian, X., Chen, Y., Tan, H.-Q., Xie, P.-J., Shao-jun, C., Fu, Y., Chen, Y., Xu, W., & Wei, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-14408-7 · Cited by 42
Obesity Accelerates Age Defects in Mouse and Human B Cells
Frasca, D., & Blomberg, B. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02060 · Cited by 44
The liver in obesity and type 2 diabetes mellitus
Li, Z., Clark, J. M., & Diehl, A. M. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00060-0 · Cited by 46
“Inhibition of inhibitor kappa beta kinase b (IKKb), an enzyme that normally activates nuclear factor kB (NF-kB; the transcription factor that induces TNFa gene expression) [45, Liou, 1993 #140] by pharmacologic inhibitors or genetic manipulation abolishes insulin resistance in ob/ob mice [46,47].”
BackgroundInfluentialSelf-citationThe Metabolic Syndrome as a Risk Factor for Chronic Kidney Disease: More than a Fat Chance?
Schelling, J. R., & Sedor, J. R. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141964.68839.bb · Cited by 50
Knudsen, S. H., & Pedersen, B. K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0642-1 · Cited by 41
High-fat load: mechanism(s) of insulin resistance in skeletal muscle
Lark, D. S., Fisher-Wellman, K. H., & Neufer, P. D. (2012) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2012.20 · Cited by 41
Romžová, M., Hohenadel, D., Kološtová, K., Pintérová, D., Hušáková, M., Rùzicková, Š., Dostal, C., Bošák, V., Rychlík, I., & Černá, M. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.05.006 · Cited by 41
PI3K signaling in the pathogenesis of obesity: The cause and the cure
Beretta, M., Bauer, M. W., & Hirsch, E. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.11.004 · Cited by 48
Ho, G., Xue, X., Burk, R. D., Kaplan, R. C., Cornell, E. S., & Cushman, M. (2005) · Cytokine · doi:10.1016/j.cyto.2004.08.008 · Cited by 44
IKKβ is a β-catenin kinase that regulates mesenchymal stem cell differentiation
Sui, Y., Liu, Z., Park, S., Thatcher, S. E., Zhu, B., Fernandez, J., Molina, H., Kern, P. A., & Zhou, C. (2018) · JCI Insight · doi:10.1172/jci.insight.96660 · Cited by 43
Kim, J., & Lee, J. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040188.094 · Cited by 53
Self-citationSharma, S., Morinaga, H., Hwang, V., Fan, W., Fernandez, M. O., Varki, N. M., Olefsky, J. M., & Webster, N. J. G. (2013) · Endocrinology · doi:10.1210/en.2012-2218 · Cited by 43
Lipid-induced insulin resistance is prevented in lean and obese myotubes by AICAR treatment
Bikman, B. T., Zheng, D., Reed, M. A., Hickner, R. C., Houmard, J. A., & Dohm, G. L. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00190.2009 · Cited by 41
Nitrosative modifications of protein and lipid signaling molecules by reactive nitrogen species
White, P. J., Charbonneau, A., Cooney, G. J., & Marette, A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00510.2010 · Cited by 49
Xu, M., Hu, J., Zhao, W., Gao, X., Jiang, C., Liu, K., Liu, B., & Huang, F. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300510 · Cited by 45
Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus
Salvadó, L., Serrano, L., Barroso, E., Palomer, X., & Vázquez‐Carrera, M. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.658370 · Cited by 48
“Thus, it activates the pro-inflammatory transcription factor NF-kB, which has been linked to fatty acid-induced impairment of insulin action in skeletal muscle in rodents [101,102].”
BackgroundPEDF-induced alteration of metabolism leading to insulin resistance
Carnagarin, R., Dharmarajan, A., & Dass, C. R. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.006 · Cited by 45
Paraoxonases and Chemokine (C–C Motif) Ligand-2 in Noncommunicable Diseases
Camps, J., Rodríguez‐Gallego, E., García‐Heredia, A., Triguero, I., Riera-Borrull, M., Hernández‐Aguilera, A., Luciano‐Mateo, F., Fernández‐Arroyo, S., & Joven, J. (2013) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800094-6.00007-8 · Cited by 46
“ulation of inflammatory mediators results in changes in metabolic parameters [41].”
BackgroundTranscriptional Dysregulation of Adipose Tissue Autophagy in Obesity
Maixner, N., Bechor, S., Vershinin, Z., Pecht, T., Goldstein, N., Haim, Y., & Rudich, A. (2016) · Physiology · doi:10.1152/physiol.00048.2015 · Cited by 42
Nash, A. I. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.07.010 · Cited by 55
The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus
Jiang, Y., Shui, J., Zhang, B., Chin, J.-W., & Yue, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585487 · Cited by 48
“In 2001, researchers understood that the anti-inflammatory drug salicylic salicylate greatly ameliorates IR and the symptoms of diabetes via the IKKβ/NF-κB axis (Yuan et al., 2001).”
BackgroundJeong, J., Lee, D. H., & Song, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112933 · Cited by 42
Dynamic Interplay Between Metabolic Syndrome and Immunity
Paragh, G., Seres, I., Harangi, M., & Fülöp, P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_13 · Cited by 44
Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
Zu, L., Jiang, H., He, J., Xu, C. B., Pu, S., Liu, M., & Xu, G. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039479 · Cited by 40
“Recent studies suggest that salicylate can reverse obesityand diet-induced insulin resistance by inactivating I B kinase (IKK ) (Kim et al., 2001; Yuan et al., 2001; Hundal et al., 2002).”
BackgroundResultInfluentialJung, T. W., Choi, H. Y., Lee, S. Y., Hong, H. C., Yang, S. J., Yoo, H. J., Youn, B.-S., Baik, S. H., & Choi, K. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066529 · Cited by 39
“The use of high-dose salicylates in obese, insulin resistant Zucker fatty rats and ob/ob mice significantly lowered blood glucose concentrations, improved glucose tolerance, and increased insulin sensitivity [16].”
BackgroundMobraten, K., Haugbro, T., Karlstrom, E., Kleiveland, C. R., & Lea, T. (2014) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2014.986744 · Cited by 42
Najjar, S. M., & Russo, L. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0407-3 · Cited by 45
“inflammatory, serving as negative regulators of insulin action [35–38] in humans [39, 40] and rodents [41–45].”
Subbaramaiah, K., Sue, E., Bhardwaj, P., Du, B., Hudis, C. A., Giri, D. D., Kopelovich, L., Zhou, X. K., & Dannenberg, A. J. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0140 · Cited by 39
RetractedChen, Z., Shen, H., Sun, C., Yin, L., Tang, F., Zheng, P., Liu, Y., Brink, R. A., & Rui, L. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00470.2014 · Cited by 43
Zhu, R., Zheng, J., CHEN, L., Gu, B., & Huang, S. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2555 · Cited by 40
“The IKK/I κ B α pathway is closely associated with insulin resistance (45,47); it links inflammation to insulin resistance.”
BackgroundStalin, A., Irudayaraj, S. S., Gopalsamy, R. G., Balakrishna, K., Savarimuthu Ignacimuthu, S. J., & Al-Dhabi, N. A. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.04.016 · Cited by 39
Jung, T. W., Kim, H., El‐Aty, A. M. A., & Jeong, J. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-01603-9 · Cited by 43
Nie, L., Yuan, X., Jiang, K., Jiang, Y., Yuan, J., Luo, L., Cui, S., & Sun, C. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.08.004 · Cited by 39
“By repressing nuclear factor IkappaB kinase subunit β, salicylate sensitizes insulin signaling to reverse hyperglycemia, hyperinsulinemia and dyslipidemia in obese rodents (Yuan et al. 2001).”
BackgroundLoss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction
Cruz, V. H., Arner, E. N., Wynne, K. W., Scherer, P. E., & Brekken, R. A. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.007 · Cited by 41
NLRP3 inflammasome mediate palmitate-induced endothelial dysfunction
Xing, J., Li, R., Gao, Y., Wang, M., Liu, Y., Hong, J., Dong, J., Gu, H., & Li, L. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116882 · Cited by 42
Antidiabetic, Antihyperlipidemic and Antioxidant Effects of the Flavonoids
Unnikrishnan, M. K., Veerapur, V. P., Nayak, Y., Mudgal, P. P., & Mathew, G. (2013) · Polyphenols in Human Health and Disease · doi:10.1016/b978-0-12-398456-2.00013-x · Cited by 56
BMP7 reduces inflammation and oxidative stress in diabetic tubulopathy
Li, R. X., Yiu, W. H., Wu, H., Wong, D. W. L., Chan, L. Y. Y., Lin, M. Y., Leung, J. C. K., Lai, K. N., & Tang, S. C. W. (2014) · Clinical Science · doi:10.1042/cs20140401 · Cited by 42
Haluzik, M., Gavrilova, O., & LeRoith, D. (2004) · Endocrinology · doi:10.1210/en.2003-1015 · Cited by 39
Preclinical developments in type 2 diabetes
Lenhard, J. M., & Gottschalk, W. K. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00092-3 · Cited by 44
Skeletal muscle non-shivering thermogenesis as an attractive strategy to combat obesity
Li, H., Wang, C., Li, L., & Li, L. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119024 · Cited by 38
Essential Minerals and Metabolic Adaptation of Immune Cells
Alghamdi, M. A., Gutierrez, J., & Komarnytsky, S. (2022) · Nutrients · doi:10.3390/nu15010123 · Cited by 52
“It has also been long recognized that anti-inflammatory treatments attenuate insulin resistance as observed with salicylic acid [44], salicilates [45], or aspirin [46], likely via inhibition of κB in the NF-κB inflammatory pathway.”
BackgroundOrchestration of the Adipose Tissue Immune Landscape by Adipocytes
Bradley, D. P., Deng, T., Shantaram, D., & Hsueh, W. A. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042222-024353 · Cited by 46
Zhao, S., Liu, D., Ding, L., Liu, G.-K., Yao, T., Wu, L., Li, G., Cao, S., Qiu, F., & Kang, N. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113069 · Cited by 46
Low birth weight and markers of inflammation and endothelial activation in adulthood: The ARIC study
Pellanda, L. C., Duncan, B. B., Vigo, Á., Rose, K. M., Folsom, A. R., & Erlinger, T. P. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.02.024 · Cited by 41
Ludzki, A., Paglialunga, S., Smith, B. K., Herbst, E. A. F., Allison, M. K., Heigenhauser, G. J., Neufer, P. D., & Holloway, G. P. (2015) · Diabetes · doi:10.2337/db14-1838 · Cited by 37
Nimrouzi, M., Abolghasemi, J., Sharifi, M. H., Nasiri, K., & Akbari, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110079 · Cited by 40
Obese Adipose Tissue Secretion Induces Inflammation in Preadipocytes: Role of Toll-Like Receptor-4
Renovato‐Martins, M., Moreira-Nunes, C., Atella, G. C., Barja‐Fidalgo, C., & Moraes, J. A. (2020) · Nutrients · doi:10.3390/nu12092828 · Cited by 45
“In obese animal models, inhibition of the IKK β / NF-κ B pathway by pharmacological inhibitors of IKK β , or by the genetic deletion of IKK β , improves insulin resistance [14,15].”
Yang, L., Qian, Z., Ji, H., Yang, R., Wang, Y., Liang, X., Sheng, L., Zhao, B., & Zhang, X. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.061 · Cited by 40
“It has been shown that salicylic acid, a traditional anti-inflammatory agent, could reverse diet or fat-induced insulin insensitivity by inhibiting IKKβ (Kim et al., 2001; Yuan et al., 2001).”
BackgroundTreating insulin resistance: future prospects
Bailey, C. J. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.002 · Cited by 38
van Meijl, L. E. C., Popeijus, H. E., & Mensink, R. P. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900438 · Cited by 42
Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative action
Tauseef, M., Sharma, K. K., & Fahim, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.029 · Cited by 40
Handy, R. M., & Holloway, G. P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1151389 · Cited by 38
“Nonetheless, it has been proposed that mitochondrial-ROS activate the nuclear factor-κβ pathway (NF-κβ/Iκβ/IKKβ pathway) resulting in serine phosphorylation of IRS-1, and attenuation of insulin signalling in a similar manner to DAGs (Yuan et al., 2001; Sinha et al., 2004).”
ResultInfluentialWu, Y., Yan, B., Xu, W., Guo, L., Wang, Z., Li, G., Hou, N., Zhang, J., & Ling, R. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.39936 · Cited by 37
“Previous clinical trials demonstrated that aspirin can regulate lipid metabolism [41], and more recently, studies have linked fatty acid synthesis with oncogenic myc activity [42].”
BackgroundTamboli, R. A., Hajri, T., Jiang, A., Marks-Shulman, P. A., Williams, D. B., Clements, R. H., Melvin, W., Bowen, B. P., Shyr, Y., Abumrad, N. N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028577 · Cited by 37
“Elevated proinflammatory cytokines such as TNF-a as well as increased proinflammatory pathway activation such as NFkB signaling through IkB kinase (IKK) and JNK-mediated phosphorylation of IRS-1 are also observed in various models of obesity induced insulin resistance [16,17,18,19].”
BackgroundCynis, H., Kehlen, A., Haegele, M., Hoffmann, T., Heiser, U. F., Fujii, M., Shibazaki, Y., Yoneyama, H., Schilling, S., & Demuth, H. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12020 · Cited by 41
“…cytokines and chemokines are up-regulated in human NAFLD as shown for, for example, TNF-a or CCL2 (Hui et al. 2004; Haukeland et al. 2006) and disruption of NF-jB signalling reversed symptoms related to insulin resistance and obesity in experimental animal models (Yuan et al. 2001).”
BackgroundKaragiannides, I., Bakirtzi, K., Kokkotou, E. G., Stavrakis, D. G., Margolis, K. G., Thomou, T., Giorgadze, N., Kirkland, J. L., & Pothoulakis, C. (2011) · Endocrinology · doi:10.1210/en.2011-1170 · Cited by 38
Kiràly, M. A., Campbell, J. E., Park, E., Bates, H. E., Yue, J. T. Y., Rao, V., Matthews, S. G., Bikopoulos, G. J., Rozakis-Adcock, M., Giacca, A., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90575.2008 · Cited by 42
Antiinflammatory effects of aspirin in ACS: relevant to its cardio coronary actions?
Schrör, K., & Hohlfeld, T. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-03-0191 · Cited by 37
Lee, H., Jee, Y., Hong, K., Hwang, G. S., & Chun, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083471 · Cited by 38
“induces PTP1B expression of muscle in vivo [27] and PTP1B is”
BackgroundAtherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease
Alkhouri, N., Carter-Kent, C. A., Elias, M., & Feldstein, A. E. (2011) · Clinical Lipidology · doi:10.2217/clp.11.19 · Cited by 41
Salicylates Increase Insulin Secretion in Healthy Obese Subjects
Fernández‐Real, J. M., López‐Bermejo, A., Ropero, A. B., Piquer, S., Nadal, Á., Bassols, J., Casamitjana, R., Gomis, R., Arnáiz, E., Pérez, I., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1212 · Cited by 42
Chen, Y., Cheng, Y., Tzeng, C., Lee, Y., Chang, Y.-N., Lee, S.-C., Tsai, C.-C., Chen, J., Tzen, J. T. C., & Chang, S. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-30 · Cited by 35
“Metabolic syndrome, which comprises IR, obesity, hyperlipidemia, and hypertension [6,7], can increase the risk of cardiovascular disease by 79%, especially large-vessel disease and DM [8,9].”
Korkmaz‐Icöz, S., Said, S. A., Radovits, T., Li, S., Brune, M., Hegedűs, P., Atmanli, A., Ruppert, M., Brlecic, P., Lehmann, L., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0383-8 · Cited by 37
“Furthermore, recent studies have revealed that proinflammatory cytokines can cause the sustained development of insulin resistance [8], and that anti-inflammatory medications may reverse this process [9, 10].”
BackgroundVascular risk in obesity: Facts, misconceptions and the unknown
King, R., & Ajjan, R. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116675488 · Cited by 43
Faghihimani, E., Aminorroaya, A., Rezvanian, H., Adibi, P., Ismail‐Beigi, F., & Amini, M. (2012) · Endocrine Practice · doi:10.4158/ep12064.or · Cited by 37
THP-1 Macrophages and SGBS Adipocytes ? A New Human in vitro Model System of Inflamed Adipose Tissue
Keuper, M., Dzyakanchuk, A. A., Amrein, K. E., Wabitsch, M., & Fischer‐Posovszky, P. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00089 · Cited by 39
“Another feature is the activation of inflammatory signaling pathways including inhibitor of NF-κB kinase beta (IKK-β) and c-Jun NH2-terminal kinase (JNK; Yuan et al., 2001; Hirosumi et al., 2002).”
BackgroundAcetylsalicylic Acid Improves Lipid-Induced Insulin Resistance in Healthy Men
Möhlig, M., Freudenberg, M., Bobbert, T., Ristow, M., Rochlitz, H., Weickert, M. O., Pfeiffer, A. F. H., & Spranger, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1889 · Cited by 36
Cremonini, E., & Oteiza, P. I. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.03.027 · Cited by 39
Autophagy-mediated metabolic effects of aspirin
Castoldi, F., Humeau, J., Martins, I., Lachkar, S., Loew, D., Dingli, F., Durand, S., Enot, D., Bossut, N., Chery, A., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00365-0 · Cited by 27
Pascual, G., Ricote, M., & Hevener, A. L. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1503 · Cited by 12
“Not only do these signaling molecules cause transcriptional activation of nuclear factor (NF)κ B or activation protein-1 family members, but each of these kinases also promote serine phosphorylation of insulin receptor substrate (IRS)-1, which diminishes downstream insulin signal transduction [6,12-15] .”
Background
Metadata
- Authors
- Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E.
- Affiliations
- Joslin Diabetes Center (US)
- Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- Corresponding author
- Yuan, Minsheng
- Konstantopoulos, Nicky
- Lee, Jongsoon
- Shoelson, Steven E.
- Venue
- Science
- Published
- 2001-08-31
- Volume
- 293
- Issue
- 5535
- Pages
- 1673-1677
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2031637294
- Cited by
- 1,884
- References
- 26
- Citations by year
- 2026: 16 · 2025: 29 · 2024: 27 · 2023: 36 · 2022: 41 · 2021: 51 · 2020: 51 · 2019: 61 · 2018: 54 · 2017: 70 · 2016: 78 · 2015: 93 · 2014: 109 · 2013: 124 · 2012: 99
- FWCI
- 56.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29dk045493-05)
- National Institute of Allergy and Infectious Diseases (AI 43477)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 51729, DK45493)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- insulin resistance, obesity, salicylates, IκB kinase β, insulin signaling, inflammation, type 2 diabetes, hyperinsulinemia, hyperglycemia, dyslipidemia, high-fat diet, ob/ob mice, insulin sensitization, cyclooxygenase
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Blood Glucose, Cell Line, Dietary Fats, Glucose Tolerance Test, Insulin, Insulin Resistance, Lipids, Liver, Male, Mice, Obese, Muscles, Obesity, Phosphorylation, Prostaglandin-Endoperoxide Synthases, Rats, Zucker, Receptor, Insulin, Sodium Salicylate, Tumor Necrosis Factor-alpha, Signal Transduction, Protein Serine-Threonine Kinases, Gene Deletion, Gene Targeting, Mice, Rats, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.